Search
Filter Applied Clear All
Filter Results
- Resource Type
- Article1
- Article Type
- Clinical Study1
- Clinical Trial1
- Controlled Clinical Trial1
- English Abstract1
- Result From
- PubMed1
-
Year
- Journal Title
- Dtsch Med Wochenschr1
Search Results
- ArticleBachmann F, Hartl W.Dtsch Med Wochenschr. 1977 Dec 02;102(48):1772-5.MK-231 (Sulindac), 200-400 mg daily, was given to 25 patients with rheumatoid arthritis. The therapeutic response was good and there were no side effects at all. The drug should be used more frequently than heretofore in the drug treatment of symptoms of rheumatoid arthritis.